珈创生物 (874185.OC)

+ 收藏

现金流量表(珈创生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 55,691,446.3128,547,980.03116,135,872.3156,393,491.6126,082,064.43
 收到的税费返还(元) --2,930,861.06--
 收到其他与经营活动有关的现金(元) 3,809,566.113,064,952.814,942,171.302,832,550.602,240,970.52
 经营活动现金流入小计(元) 59,501,012.4231,612,932.84124,008,904.6759,226,042.2128,323,034.95
 购买商品、接受劳务支付的现金(元) 11,073,995.285,295,901.9619,474,582.739,276,362.774,661,126.73
 支付给职工以及为职工支付的现金(元) 23,042,510.0211,896,080.8047,968,785.9625,753,686.5315,331,560.81
 支付的各项税费(元) 6,232,610.983,153,650.885,381,595.762,302,363.47162,764.56
 支付其他与经营活动有关的现金(元) 4,819,534.282,251,513.429,831,397.494,257,914.492,148,911.83
 经营活动现金流出小计(元) 45,168,650.5622,597,147.0682,656,361.9441,590,327.2622,304,363.93
 经营活动产生的现金流量净额(元) 14,332,361.869,015,785.7841,352,542.7317,635,714.956,018,671.02
二、投资活动产生的现金流量
 收到其他与投资活动有关的现金(元) 61,052,054.7961,052,054.79---
 投资活动现金流入小计(元) 61,052,054.7961,052,054.79---
 购建固定资产、无形资产和其他长期资产支付的现金(元) 7,808,358.825,787,159.8617,963,408.5110,116,455.496,160,393.49
 投资支付的现金(元) --1,000,000.00--
 支付其他与投资活动有关的现金(元) 60,000,000.0060,000,000.0060,000,000.0060,000,000.0060,000,000.00
 投资活动现金流出小计(元) 67,808,358.8265,787,159.8678,963,408.5170,116,455.4966,160,393.49
 投资活动产生的现金流量净额(元) -6,756,304.03-4,735,105.07-78,963,408.51-70,116,455.49-66,160,393.49
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 200,000.00200,000.0010,000,006.25--
  其中:子公司吸收少数股东投资收到的现金(元) 200,000.00200,000.00---
 筹资活动现金流入小计(元) 200,000.00200,000.0010,000,006.25--
 偿还债务支付的现金(元) --20,000,000.0020,000,000.0020,000,000.00
 分配股利、利润或偿付利息支付的现金(元) --15,101,750.00101,750.00101,750.00
 支付其他与筹资活动有关的现金(元) 1,762,564.21876,142.653,310,619.401,715,217.00709,772.85
 筹资活动现金流出小计(元) 1,762,564.21876,142.6538,412,369.4021,816,967.0020,811,522.85
 筹资活动产生的现金流量净额(元) -1,562,564.21-676,142.65-28,412,363.15-21,816,967.00-20,811,522.85
五、现金及现金等价物净增加额(元) 6,013,493.623,604,538.06-66,023,228.93-74,297,707.54-80,953,245.32
 加:期初现金及现金等价物余额(元) 67,674,262.4867,674,262.48133,697,491.41133,697,491.41133,697,491.41
 期末现金及现金等价物余额(元) 73,687,756.1071,278,800.5467,674,262.4859,399,783.8752,744,246.09
补充资料:
 净利润(元) 14,135,941.588,379,401.8346,623,896.5823,098,420.1910,840,959.86
 资产减值准备(元) 2,218,250.30280,734.73467,408.85875,195.04-
 固定资产和投资性房地产折旧(元) 5,515,185.222,734,802.829,246,296.994,278,597.032,097,240.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 5,515,185.222,734,802.829,246,296.994,278,597.032,097,240.84
 无形资产摊销(元) 305,842.43152,921.22611,684.88305,842.44152,921.22
 长期待摊费用摊销(元) 2,377,297.531,199,667.082,712,139.73640,540.87320,078.07
 处置固定资产、无形资产和其他长期资产的损失(元) -2,867.28-1,436.54-24,438.79-24,438.79-24,438.79
 固定资产报废损失(元) 4,702.744,039.904,035.333,711.062,039.04
 财务费用(元) 460,336.86229,622.98835,972.53394,587.20242,359.68
 投资损失(元) 248,493.0789,892.18411,031.49146,996.91118,550.76
 递延所得税(元) -426,034.88-40,083.45-282,756.23-264,257.92-146,464.82
  其中:递延所得税资产减少(元) -198,634.154,716.55-1,084,766.47-40,801.2443,131.49
 递延所得税负债增加(元) -227,400.73-44,800.00802,010.24-223,456.68-189,596.31
 存货的减少(元) -759,272.23-4,454,876.31-1,034,003.51-3,100,635.58-1,819,523.85
 经营性应收项目的减少(元) -6,990,790.342,430,800.47-8,755,863.28-1,256,029.002,727,817.90
 经营性应付项目的增加(元) -4,616,784.96-2,605,033.60-12,922,940.41-9,133,684.64-9,215,228.51
 现金的期末余额(元) 73,687,756.1071,278,800.54-59,399,783.8752,744,246.09
 减:现金的期初余额(元) 67,674,262.4867,674,262.48-133,697,491.41133,697,491.41
 现金及现金等价物的净增加额(元) 6,013,493.623,604,538.06-66,023,228.93-74,297,707.54-80,953,245.32
公告日期 2024-08-282024-06-182024-02-282023-08-302023-06-07
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院